Disease Markers / 2014 / Article / Tab 1

Research Article

Identification of Human Tissue Kallikrein 6 as a Potential Marker of Laryngeal Cancer Based on the Relevant Secretory/Releasing Protein Database

Table 1

KLK6 levels in the plasma of laryngeal SCC patients and controls.

CharacteristicsKLK6 levels (ng/mL) value
MedianInterquartile range

All individuals4.762.34
Diagnostic category
Anatomical region of cancer
Disease stage
 I + II5.443.600.375
 III + IV4.764.48
T stage
Lymph node status
Tumor differentiation

KLK6: kallikrein 6.
Comparisons of the plasma KLK6 levels between two independent sample cohorts were assessed by the Mann-Whitney test, and those among more than two independent cohorts were assessed by the Kruskal-Wallis test. *Benign versus health; cancer versus benign; cancer versus health.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.